FindTrial
Sign In

Establishment of a risk assessment tool for pregnancy-associated venous thromboembolism and its clinical application in Beijing

Establishment of a risk assessment tool for pregnancy-associated venous thromboembolism and its clinical application in Beijing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015848
Enrollment
Unknown
Registered
2018-04-24
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy-associated venous thromboembolism

Interventions

Pregnancy population:NO

Sponsors

Beijing Obstetrics & Gynecology Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Pregnant patients who visit the Beijing Maternity Hospital affiliated with Capital Medical University between June 2018 and December 2019 will be invited to participate in this observational cohort study with a target number of 4,420 patients. Patient enrollment will be voluntary and involve detailed observations and evaluation. Patients will sign the informed consent for regular prenatal and follow-up examinations until 6 weeks postpartum.

Exclusion criteria

Exclusion criteria: 1) Miscarriage before 12 weeks of gestational age; and 2) severe heart, liver, or kidney dysfunction, as well as hematologic or immune system disorders.

Design outcomes

Primary

MeasureTime frame
Complete Compression ultrasound;—

Countries

China

Contacts

Public ContactCHEN YI

Beijing Obstetrics & Gynecology Hospital, Capital Medical University

bjfcyycy@sina.com+86 13601354010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026